Oral pharmacological treatment of X-linked dystonia parkinsonism: Successes and failures.
- Author:
Jamora Roland Dominic G
;
Jamora Roland Dominic G
;
Diesta Cid Czarina E
;
Pasco Paul Matthew D
;
Lee Lillian V
- Publication Type:Journal Article
- Keywords: Anticholinergic
- MeSH: Human; Baclofen; Cholinergic Antagonists; Clonazepam; Clozapine; Dystonia; Dystonic Disorders; Genetic Diseases, X-linked; Parkinsonian Disorders; Tetrabenazine; Levodopa
- From: Philippine Journal of Neurology 2012;16(1):79-82
- CountryPhilippines
- Language:English
-
Abstract:
There is a paucity of published literature on the different oral medications tried for X-linked dystonia parkinsonism (XDP). In practice, most XDP patients are tired on medication typically used for patients with generalized dystonia. These drugs include anticholinergic agents, baclofen, clonazepam and other ben-zodiazepines, tetrabenazine, and clozapine. Although several articles have shown that these classess of drugs are beneficial for patients with generalized dystonia, none been systematically studied specifically for XDP patients. We are currently conducting the first randomized, placebo-controlled trial on the medications that have been used in XDP.